ERBB2 and breast carcinoma: Moreover, a Th2 signature is selectively enriched in poor outcome basal breast cancers and an elevated Th1/Th2 ratio is highly predictive of good outcome in HER2 and basal breast cancer patients (Kristensen et al., 2012).